Home
Clinical Resources Search
PQI: Use of Rasburicase (Elitek®) for Treatment of Tumor Lysis Syndrome

Use of Rasburicase (Elitek®) for Treatment of Tumor Lysis Syndrome

Download PQI pdf

Last Updated: September 27, 2022

By: Marie C. Rush, PharmD, CPP, BCOP

About this PQI

The purpose of this PQI is to identify appropriate dosing of rasburicase based upon uric acid levels.

More About This PQI

PQI in Action Articles:

PQI_elitek_treatment_tumor_lysis pdf

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Frequently Searched

Supported by

Use of Rasburicase (Elitek®) for Treatment of Tumor Lysis Syndrome

About this PQI

More About This PQI

PQI in Action Articles:

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Encorafenib (Braftovi) + Cetuximab (Erbitux) + FOLFIRI for BRAF V600E-Positive Metastatic Colorectal Cancer

PQI: Reflex Biomarker Testing in Metastatic Colorectal Cancer: Implementing BRAF and MSI Assessment

PQI: Amivantamab and Hyaluronidase plus Lazertinib Patient Management

PQI: Belantamab Mafodotin (Blenrep) for the Management of Multiple Myeloma

PQI in Action: Capivasertib (Truqap) Patient Management

PQI in Action: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)

PQI in Action: Darolutamide (Nubeqa)

PQI in Action: Zolbetuximab (Vyloy) for Gastroesophageal Cancers

S10 E14: Optimizing Access Through OOLD

S10 E12: Inside GU Oncology with Uromigos Co-Host

S10 E15: From Student to Fellow to Leader: Exploring Pharmacy Fellowships

S10 E13: Oncology Unfiltered: AI and the Future of Cancer Care

Toolkit: Simplify CLL Tracking in Oncology Practices

Toolkit: Optimize CLL Care in Epic

Treatment Support Kit: Elranatamab

Treatment Support Kit: Bi-Specific

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Gilteritinib

PQI: Revumenib (Revuforj) for the Management of Acute Leukemia

Cladribine, Cytarabine, and Venetoclax

Decitabine and Venetoclax

Azacitidine and Venetoclax

Ziftomenib

Lisocabtagene Maraleucel

Acalabrutinib and Venetoclax

Ibrutinib and BR

Ibrutinib and Obinutuzumab

S7 Ep 8: Sickle Cell Disease Insights

PQI: Venetoclax (Venclexta) for the Treatment of Acute Myeloid Leukemia

PQI: Venetoclax (Venclexta®) Use in Chronic Lymphocytic Leukemia

PQI in Action: Use of Rasburicase (Elitek®) For Treatment of Tumor Lysis Syndrome

PQI in Action: Use of Rasburicase (Elitek®) For Treatment of Tumor Lysis Syndrome

PQI in Action: Use of Rasburicase (Elitek®) For Treatment of Tumor Lysis Syndrome

PQI in Action: Zanubrutinib (Brukinsa®) Patient Selection and Management in Mantle Cell Lymphoma

Step Edit Series

Tisagenlecleucel

Nogapendekin Alfa Inbakicept and Bacillus Calmette-Guérin

Acalabrutinib and Venetoclax